Vaishali Pharma Appoints Independent Directors and Defers Preferential Issue
Vaishali Pharma Ltd 路 Outcome 路 06 Nov 2026, 2:04 am
Vaishali Pharma Appoints Independent Directors and Defers Preferential Issue Vaishali Pharma Limited's Board of Directors, at its meeting on 5th Nov'26, approved the appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Additional Directors under the Non-Executive Independent category for a five-year term, subject to shareholder approval. Additionally, the Board considered a proposal for the issuance of equity shares via a preferential issue but decided to defer the matter for further evaluation and consideration, resulting in no formal decision taken during the meeting.
Original exchange filing (PDF)
More announcements from Vaishali Pharma Ltd
- Vaishali Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 15 Nov 2026
- Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 14 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Non- Executive Independent Director of the company w.e.f. November 05, 2026. 路 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising. 路 03 Nov 2026
- To consider Fund Raising and other business matters 路 03 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about General Updates 路 17 Oct 2026
